Journal of Clinical Nephrology and Therapeutics

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Rapid Communication - Journal of Clinical Nephrology and Therapeutics (2022) Volume 6, Issue 5

Renal artery stenosis: etiology, pathophysiology, treatment and management

Helen Thomson*

Division of Nephrology and Hypertension, Oregon Health & Science University, Portland, United States

*Corresponding Author:
Helen Thomson
Division of Nephrology and Hypertension
Oregon Health & Science University
Portland, United States

Received: 30-Aug-2022, Manuscript No. AACNT-22-73762; Editor assigned: 01-Sep-2022, PreQC No. AACNT-22-73762(PQ); Reviewed: 15-Sep-2022, QC No. AACNT-22-73762; Revised: 19-Sep-2022, Manuscript No. AACNT-22-73762(R); Published: 26-Sep-2022, DOI: 10.35841/aacnt-6.5.125

Citation: Thomson H. Renal artery stenosis: Etiology, pathophysiology, treatment and management. J Clin Nephron Ther. 2022;6(5):125

Visit for more related articles at Journal of Clinical Nephrology and Therapeutics


Renal artery stenosis is restricting of the either of renal arteries. It is the significant reason for hypertension and as per a few reports is the reason for hypertension in 1% to 10% of the 50 million individuals in the United States. Atherosclerosis or fibromuscular dysplasia most frequently causes it. Other related complexities of renal artery stenosis are ongoing kidney disease and end-stage renal disease [1].


There are two significant reasons for one-sided renal artery stenosis (RAS) [2]

Atherosclerosis (60% to 90%): Atherosclerosis essentially influences patients (men beyond 45 years old years) and for the most part includes the aortic opening or the proximal 2cm of the vitally renal course. This problem is especially normal in patients who have atherosclerosis, however, can likewise happen as a moderately isolated renal lesion. Any of the multiple renal arteries might be impacted. Risk factors for atherosclerosis incorporate dyslipidemia, cigarette smoking, viral contamination, insusceptible injury, and expanded homocysteine levels.

Fibromuscular dysplasia (10% to 30%): When compared to atherosclerosis, fibromuscular dysplasia most frequently affects women less than the age of 50 years and regularly includes the center and distal principal renal artery or the intrarenal branches.

Other more uncommon causes (under 10%) incorporate thromboembolic illness, blood vessel analyzation, infrarenal aortic aneurysm, vasculitis (Takayasu arteritis, Buerger infection, polyarteritis nodosa, and post radiation) and neurofibromatosis type 1, retroperitoneal fibrosis.


The prevalence of renal corridor stenosis is presumably under 1% of patients with gentle hypertension however can increment to as high as 10% to 40% in patients with intense (regardless of whether superimposed on a prior rise in blood pressure), extreme, or refractory hypertension. A few studies report the prevalence of unilateral stenosis (contrasted and two-sided stenosis) roughly from 53% to 80% [3].

Studies recommend that ischemic nephropathy might be the reason for 5% to 22% of advanced renal disease in all patients older than 50 years. Patients with fibromuscular dysplasia have contribution of the renal arteries in generally 75% to 80% of cases. About 66% of patients have association of various renal arteries. Fibromuscular dysplasia is more normal in females than in males.

Pathogenesis of hypertension: In atherosclerosis, the initiator of endothelial injury although not surely knew can be, dyslipidemia, cigarette smoking, viral disease, immune injury, or increased homocysteine levels. At the injury site, porousness to Low-Thickness Lipoprotein (LDL) and macrophage migration increases with resulting multiplication of endothelial and smooth muscle cells and extreme formation of atherosclerotic plaque [4]. Renal blood flow, which is fundamentally more prominent than the perfusion to different organs, alongside glomerular hairlike hydrostatic pressure is a significant determinant of the Glomerular Filtration Rate (GFR). In patients with renal artery stenosis, the chronic ischemia delivered by the obstruction of renal blood flow leads to versatile changes in the kidney which incorporate the formation of collateral blood vessels and discharge of renin by juxtaglomerular apparatus. The renin enzyme plays a significant part in keeping up with homeostasis in that it changes over angiotensinogen to angiotensin I. Angiotensin I have then converted completely to angiotensin II with the assistance of an Angiotensin-Converting Enzyme (ACE) in the lungs. Angiotensin II is responsible for vasoconstriction and release of aldosterone which causes sodium and water retention, in this manner bringing about auxiliary hypertension or renovascular hypertension.

Pathogenesis of chronic renal insufficiency: Glomerular Filtration Rate (GFR) is auto regulated by angiotensin II and other modulators between the afferent and efferent arteries routes. The support of GFR fizzles when renal perfusion pressure falls under 70 mmHg to - 85 mmHg. Subsequently critical functional impairment of auto regulation, leading to a decrease in the GFR, is simply prone to be seen until blood vessel luminal narrowing exceeds 50%. Studies show that a moderate decrease in renal perfusion pressure (up to 40%) and renal blood stream (mean 30%) cause decrease in glomerular filtration, in any case, tissue oxygenation inside the kidney cortex and medulla can adjust without the development of severe. As a deduction patient at a beginning phase can be treated with clinical treatment without moderate loss of capability or irreversible fibrosis by and large, here and there for a long time.

It is accounted for that further developed stenosis comparing to a 70% to 80% of vascular impediment prompts verifiable cortical hypoxia, and it is recommended that this hypoxia produce rarefaction of micro vessels, as well as initiation of inflammatory and oxidative pathways that cause interstitial fibrosis. Hence loss of renal function in renovascular disease as well as being a normally reversible outcome of antihypertensive treatment can reflect a gradual restricting of the renal conduits or potentially moderate natural renal illness. Ultimately, well established parenchymal injury turns into an irreversible cycle. Right now, reestablishing renal blood flow gives no recuperation of renal function or clinical benefit.

Treatment and management: Initial treatment for renal artery stenosis is perception rather than revascularization when either stenosis is half to 80%, and scintigraphy discoveries are negative, or the level of stenosis is under 50%. The administration which includes sequential control every 6 months with duplex examining, exact correction of dyslipidemia, utilization of medications that block platelet accumulation, may require at least three unique medications to control hypertension. Preferably Angiotensin-Converting Enzyme (ACE) inhibitors or Angiotensin Receptor Blockers (ARBs) are utilized for the reason. Unfortunately, these two classes of drugs can likewise lead to increased serum creatinine levels and hyperkalemia, restricting their utility. In such a case, calcium channel blockers are an expected substitution. Severe control of serum cholesterol, with the utilization of statins in the regimen.

The level of renal artery stenosis that would justify any mediation attempt is greater than 80% in patients with bilateral stenosis or stenosis in a single working kidney whether or not they have renal deficiency or not.

At the point when renal function is typical or almost normal, revascularization is suggested for counteraction of renal deficiency if the patient satisfies the mentioned standards [5].

• The degree of renal artery stenosis is more noteworthy than 80% to 85%

• The degree of RAS is 50% to 80%, and captoprilupgraded scintigraphy exhibits the presence of intrarenal renal corridor stenosis.

• At the point when renal function abnormality is available, the criteria for revascularization are as per the following:

• The serum creatinine level is under 4 mg/dL

• The serum creatinine level is greater than 4 mg/dL however with a potential ongoing renal artery thrombosis

• The level of stenosis is higher than 80%

• The serum creatinine level increases after administration of angiotensin-changing over compound inhibitors

• The level of stenosis is half to 80%, and the scintigraphy results are positive for RAS.


  1. Van Twist DJ, Houben AJ, de Haan MW, et al. Pathophysiological differences between multifocal fibromuscular dysplasia and atherosclerotic renal artery stenosis. J Hypertens. 2017;35(4):845-52.
  2. Indexed at, Google Scholar, Cross Ref

  3. Al-Katib S, Shetty M, Jafri SM, et al. Radiologic assessment of native renal vasculature: a multimodality review. Radiographics. 2017;37(1):136-56.
  4. Indexed at, Google Scholar, Cross Ref

  5. Tetteh PW, Antwi-Boasiako C, Gyan B, et al. Impaired renal function and increased urinary isoprostane excretion in Ghanaian women with pre-eclampsia. Res rep trop Med. 2013;4:7.
  6. Indexed at, Google Scholar, Cross Ref

  7. Ricco JB, Belmonte R, Illuminati G, et al. How to manage hypertension with atherosclerotic renal artery stenosis? J Cardiovasc Surg. 2016;58(2):329-38.
  8. Indexed at, Google Scholar, Cross Ref

  9. Textor SC. Renal arterial disease and hypertension. Medi Clinic. 2017;101(1):65-79.
  10. Indexed at, Google Scholar, Cross Ref

Get the App